Harvard Drug Group Recalls Alprazolam Tablets Due to Unknown Impurity Risk
Harvard Drug Group recalls 0.25mg Alprazolam tablets with unknown impurity. Consumers should contact the manufacturer for details on affected lots.
Recall notice
Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.
Contact the company
What happened, in plain English
The Harvard Drug Group is recalling 0.25 mg Alprazolam tablets that failed impurity tests. This could pose a risk of unknown harmful substances in the medication. Read more at govinfonow.com/recall/41167-harvard-drug-group-recalls-alprazolam-tablets-due-to-unknown-impurity.
Source Summary by GovInfoNow · govinfonow.com/recall/41167-harvard-drug-group-recalls-alprazolam-tablets-due-to-unknown-impurity · Updated October 7, 2026 · FDA enforcement record: FDA #D-0013-2018
Cite this page
“Harvard Drug Group Recalls Alprazolam Tablets Due to Unknown Impurity Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41167-harvard-drug-group-recalls-alprazolam-tablets-due-to-unknown-impurity. Based on FDA recall #D-0013-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0013-2018%22&limit=1).
Why it’s dangerous
The tablets failed impurity tests, indicating the presence of an unknown harmful substance. This could lead to potential health risks if the impurity is toxic.
Who’s affected
Prescription users of Alprazolam tablets from Watson Pharma in India. Those with the specific lot number 1274C151A are most at risk.
How to tell if you have this one
Check for the lot number 1274C151A on the packaging. The product is a 0.25 mg Alprazolam tablet with NDC 0904-5858-61.
- Brand
The Harvard Drug Group- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 1274C151A on the packaging to confirm if it is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.6 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0013-2018 (September 26, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0013-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.